The Bioscience Network Presents The Money of Invention-Current Trends in Venture Capital in Biotech and Pharma
Thursday, May 3 2012
5:30 pm – 8:30 pm
Location: Broad Institute 415 Main St., Cambridge, MA 02142
The Biotech/Pharma industry is rapidly changing in an effort to meet the current demands from the market, regulators, investors and economic pressures. Please join us for an interactive discussion as we aim to immerse ourselves into the current trends in biotech venture funding. We will draw on the panel's experience and reflect on current and emerging business models, influences from macroeconomic factors, exit opportunities, new collaborative models and much more.
5:30-6:30pm: Cocktails, Hors d'oeuvres and Networking
6:30-8:00pm: Panel Discussion
Bruce Booth, Partner, Life Sciences Group, Atlas Venture
Daphne Zohar, Founder, Managing Partner, PureTech Ventures
Jason Rhodes, Executive Vice President and Chief Business Officer, Epizyme Inc.
Barrett Bready, President and Chief Executive Officer, Nabsys Inc.
Vin Miles, Venture Partner, Abingworth, LLP
The Bioscience Network (TBN)
TBN is a non-profit organization formed to provide individuals in the bioscience industry with opportunities for networking and career development. TBN is the premier resource for professionals in the bioscience industry focused solely for the biosciences professional.
With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. The firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com.